- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05648773
COVID-19 Booster Incentives
August 9, 2023 updated by: Mireille Jacobson, University of Southern California
COVID-19 Booster Incentives in a County-Run Health System
The goal of this work is to understand whether small financial incentives and messaging can increase the take-up of COVID-19 boosters among patients empaneled at a county public health system.
The motivation for this work is the relatively low take-up of COVID-19 boosters.
In California, where our experiment is based, only 59% of the population has been boosted, with only 13% receiving the recommended bivalent booster (State of California, 2022).
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
57893
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Martinez, California, United States, 94553
- Contra Costa Health Plan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age: 18 and above
- At least one COVID-19 vaccination (primary series or monovalent booster) but no vaccination dose within the past 2-months.
- Active phone number or email
Exclusion Criteria:
1. Opt-out of health system messaging
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Message Only
Email or SMS Booster Vaccination Reminder
|
Booster reminder message
|
|
Placebo Comparator: Control
No message or financial incentive
|
Treatment as usual; no additional message and no incentive.
|
|
Experimental: Message + Financial Incentive
Email or SMS Booster Vaccination Reminder + Offer of a financial incentive for getting boosted in the next 2 weeks.
|
Booster reminder message
Financial Incentive for getting boosted within 2-weeks of the message
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Vaccine booster
Time Frame: 2 weeks
|
Received a booster vaccination within 2-weeks of message.
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 8, 2022
Primary Completion (Actual)
December 23, 2022
Study Completion (Actual)
December 23, 2022
Study Registration Dates
First Submitted
December 8, 2022
First Submitted That Met QC Criteria
December 8, 2022
First Posted (Actual)
December 13, 2022
Study Record Updates
Last Update Posted (Actual)
August 14, 2023
Last Update Submitted That Met QC Criteria
August 9, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- UP-21-01097
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Access Criteria
Researchers can request de-identified data from Contra Costa Health Services.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Booster Message
-
Statens Serum InstitutBill and Melinda Gates Foundation; Larix A/S; CCBR Clinical ResearchCompletedImmunization, BoosterDenmark
-
University of PennsylvaniaCompletedAvailable for Members Text Message | Checked Health Text Message | No Text MessageUnited States
-
University of GeorgiaRecruitingMessage Exposure (Sequence: Regular Then Flavor) | Message Exposure (Sequence: Flavor Then Regular) | No Message Exposure (Control Condition)United States
-
University of GeorgiaCompleted
-
VA Office of Research and DevelopmentCompleted
-
Tilburg UniversityCompletedDisclosure of Protective MessageNetherlands
-
University of OxfordCompletedAntibody Persistance After Booster Dose of Men C VaccineUnited Kingdom
-
Harvard School of Public Health (HSPH)Health Science Center of Xi'an Jiaotong UniversityCompletedText Messaging | Short Message ServiceChina
-
University of HawaiiNational Cancer Institute (NCI)Not yet recruitingYoung Adults | Vaping Behaviors | Message ExposureUnited States
-
Wuhan Union Hospital, ChinaNot yet recruitingGastrointestinal Dysfunction | Traditional Chinese Acupoint Message | Intestinal BarrierChina
Clinical Trials on Messaging
-
University of California, San FranciscoNational Institute of Mental Health (NIMH); University of Pennsylvania; University... and other collaboratorsTerminated
-
University of California, San FranciscoNational Institute of Mental Health (NIMH); University of Pennsylvania; University... and other collaboratorsRecruiting
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedSmoking Cessation | Cancer | Health BehaviorUnited States
-
Emily RosenzweigCompletedBreast Cancer Screening | Colon Cancer Screening | Annual Wellness VisitUnited States
-
Medical University of South CarolinaNational Cancer Institute (NCI)CompletedSmoking Cessation | Lung Cancer ScreeningUnited States
-
University of MinnesotaAmerican Cancer Society, Inc.; Melanoma Research AllianceCompletedMelanoma (Skin)United States
-
Penn State UniversityCompletedBehavior, HealthUnited States
-
University of DelawareCompletedDiet, Healthy | Autonomic Nervous System | Affect | Nutrition Therapy | DieteticsUnited States
-
University of Colorado, DenverNational Institute of Mental Health (NIMH)CompletedHIV InfectionsUnited States
-
University of UtahNational Cancer Institute (NCI); AmeriSpeak - NORCCompleted